Kazumasa Minami

Associate Professor

Osaka University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kazumasa Minami is an Associate Professor at The University of Osaka, Japan. His research primarily focuses on the fields of radiotherapy, cancer biology, and the development of novel anticancer therapies. Recent publications include studies on carbon ion spatially fractionated radiotherapy, the biological effectiveness of proton and carbon-ion beams, and the potential of new compounds as radiosensitizers in cancer treatment.

Articles (7)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Collaborators (2)

Masashi Yagi

Endowed Chair Assistant Professor

Osaka University

JAPAN

View details

Melissa Fishel

Assistant Professor

Indiana State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kazumasa Minami

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Quantitative assessment of delivered dose in carbon ion spatially fractionated radiotherapy (C-SFRT) and biological response to C-SFRT

P18: Novel Anticancer Peptide from Induced Tumor-Suppressing Cells Targeting Breast Cancer and Bone Metastasis

Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma

A Consistent Protocol Reveals a Large Heterogeneity in the Biological Effectiveness of Proton and Carbon-Ion Beams for Various Sarcoma and Normal-Tissue-Derived Cell Lines

Poly (ADP-ribose) polymerase inhibitors sensitize cancer cells to hypofractionated radiotherapy through altered selection of DNA double-strand break repair pathways

High Dose Local Photon Irradiation Is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance the Abscopal Response in a Murine Pancreatic Carcinoma Model

Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening

Collaborators (2)

Masashi Yagi

Melissa Fishel

Make your next move.